In a major step forward for pet health, ExeGi Pharma LLC has announced the launch of Visbiome Vet GI Care+ in Canada.

This high-potency probiotic for dogs and cats contains an impressive 112.5 billion live beneficial bacteria per capsule and features the clinically proven De Simone Formulation, an eight-strain probiotic blend.

Approved by Health Canada as a Veterinary Health Product (NN.O0R3), Visbiome Vet GI Care+ aims to support pet gut health during a time when veterinary professionals increasingly seek effective solutions for gastrointestinal issues.

Dr. Caroline Mansfield, a veterinary specialist at Michigan State College of Veterinary Medicine, highlighted the product’s potential, stating, “Pets rely on a healthy, balanced gut microbiome for normal digestion and immune function. Visbiome Vet GI Care+ has some impressive clinical data, which helps to support it as an emerging tool for veterinary specialists working with challenging pet GI issues.”

The introduction of Visbiome Vet GI Care+ comes amid a growing trend towards diet-based therapies for gastrointestinal disorders in pets, supported by seven clinical studies published in peer-reviewed veterinary journals.

The product’s dosing is uniquely tailored to each animal’s weight, which sets it apart from many other veterinary probiotics.

Furthermore, to ensure maximum potency, Visbiome Vet products are shipped and stored at cold temperatures.

“There has been a consistent demand from Canadian veterinarians for Visbiome Vet GI Care+ for several years,” said Marc Tewey, CEO of ExeGi Pharma.

“Our formulation delivers one of the highest probiotic concentrations available and is backed by rigorous clinical research. We are pleased to now deliver this option to our friends in Canada,” he continued.

Visbiome Vet GI Care+ will be available exclusively through veterinarians and veterinary pharmacies throughout Canada.

Veterinary professionals can source the product from major veterinary wholesalers or directly from the manufacturer at www.VisbiomeVet.ca.